DK160270B - METHOD OF PREPARING 2,4- OR 2,4,5-SUBSTITUTED 6-HYDROXYPYRIMIDINES - Google Patents

METHOD OF PREPARING 2,4- OR 2,4,5-SUBSTITUTED 6-HYDROXYPYRIMIDINES Download PDF

Info

Publication number
DK160270B
DK160270B DK700688A DK700688A DK160270B DK 160270 B DK160270 B DK 160270B DK 700688 A DK700688 A DK 700688A DK 700688 A DK700688 A DK 700688A DK 160270 B DK160270 B DK 160270B
Authority
DK
Denmark
Prior art keywords
process according
alkali metal
amino
acid
formula
Prior art date
Application number
DK700688A
Other languages
Danish (da)
Other versions
DK160270C (en
DK700688D0 (en
DK700688A (en
Inventor
Niels Friis
Original Assignee
Cheminova As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cheminova As filed Critical Cheminova As
Priority to DK700688A priority Critical patent/DK160270C/en
Publication of DK700688D0 publication Critical patent/DK700688D0/en
Priority to PCT/DK1989/000293 priority patent/WO1990006918A1/en
Publication of DK700688A publication Critical patent/DK700688A/en
Publication of DK160270B publication Critical patent/DK160270B/en
Application granted granted Critical
Publication of DK160270C publication Critical patent/DK160270C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/34One oxygen atom
    • C07D239/36One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)

Description

DK 160270 BDK 160270 B

Den foreliggende opfindelse angår en ny fremgangsmåde til fremstilling af 2,4- eller 2,4,5-substi-tuerede 6-hydroxypyrimidiner med den almene formel IThe present invention relates to a novel process for the preparation of 2,4- or 2,4,5-substituted 6-hydroxypyrimidines of the general formula I

R3R3

5 2 I5 2 I

Vv“ I I 1 v R1Vv “I I 1 v R1

10 R10 R

hvori R1 betegner alkyl [fortrinsvis CH3, C2H5, n-C3H7, CH(CH3)2 eller n-C4Hg] eller R7 n/ , \r8 15 R2 betegner alkyl, aryl eller aralkyl [fortrinsvis CH3, C2H5, n-C3H7, CH(CH3)2, n-C4H9, C(CH3)3, C6H5 eller CH2CH2C6H5], og R3, R7 og R8 hver især betegner hydrogen, alkyl eller aralkyl [fortrinsvis H, CH3, C2Hg, n-C3H7, CH(CH3)2, 20 n-C4Hg, C(CH3)3, CH2C6H5 eller CH2CH2C6H5], eller salte heraf med en saltdannende kation, og fremgangsmåden er ejendommelig ved, at man omsætter et 3- eller 2,3-substitueret 3-aminoacrylsyrederivat med den almene formel II 25 R3wherein R 1 represents alkyl [preferably CH 3, C 2 H 5, n-C 3 H 7, CH (CH 3) 2 or n-C 4 H 9] or R 7 n /, R 2 represents alkyl, aryl or aralkyl [preferably CH 3, C 2 H 5, n-C 3 H 7, CH (CH3) 2, n-C4H9, C (CH3) 3, C6H5 or CH2CH2C6H5], and R3, R7 and R8 each represent hydrogen, alkyl or aralkyl [preferably H, CH3, C2Hg, n-C3H7, CH (CH3) 2, 20 n-C4Hg, C (CH3) 3, CH2C6H5 or CH2CH2C6H5], or salts thereof with a salt-forming cation, and the process is characterized by reacting a 3- or 2,3-substituted 3-aminoacrylic acid derivative with the general formula II R3

r2\A'° IIr2 \ A '° II

I II I

H7N XH7N X

30 hvori R2 og R3 har de ovennævnte betydninger, og X betegner OR4 eller R5 n/ \r6 hvori R4 betegner alkyl, aryl eller aralkyl [fortrins- 35 2Wherein R 2 and R 3 have the above meanings, and X is OR 4 or R 5 is R 6 wherein R 4 is alkyl, aryl or aralkyl [preferably 2

DK 160270BDK 160270B

vis CH3, C2H5, n-C3H7, CH(CH3)2, n-C4H9, C(CH3)3, C6H5 eller CH2C6H5], og R5 og R^ hver især betegner hydrogen, alkyl eller aralkyl [fortrinsvis H, CH3, C2Hg, n-C3H7, CH(CH3)2,CH3, C2H5, n-C3H7, CH (CH3) 2, n-C4H9, C (CH3) 3, C6H5 or CH2C6H5], and R5 and R3 each represent hydrogen, alkyl or aralkyl [preferably H, CH3, C2Hg , n-C 3 H 7, CH (CH 3) 2,

5 n-C4Hg, C(CH3)3, CH2C6H5 eller CH2CH2C6H5], med et nitril med den almene formel III5, n-C4Hg, C (CH3) 3, CH2C6H5 or CH2CH2C6H5], with a nitrile of the general formula III

R1-C=N IIIR1-C = N III

hvori R1 har den ovennævnte betydning, under tilstedeværelse af en base og et opløsningsmid-10 del, hvorefter man om ønsket omdanner det dannede salt til den frie pyrimidin med formlen I ved tilsætning af en syre.wherein R 1 has the aforementioned meaning, in the presence of a base and a solvent, after which, if desired, the salt formed is converted to the free pyrimidine of formula I by the addition of an acid.

Denne fremgangsmåde kan gengives ved følgende reaktionsskema: 15 R3 3 2 1 ?This procedure can be reproduced by the following reaction scheme: 15 R3 3 2 1?

R \ 2 IR \ 2 I

c' c' R v .Cv ν·ΟΗ I j 1. Basec 'c' R v .Cv ν · ΟΗ I j 1st Base

h2n X -> I IIh2n X -> I II

20 + 2. Syre Nv N20 + 2. Acid Nv N

Il RlIl Rl

RR

25 hvori de forskellige symboler har de ovennævnte betydninger .25 wherein the various symbols have the above meanings.

Fremgangsmåden kan beskrives som reaktionen mellem en 3-aminoacrylsyreester eller et 3-aminoacrylsyre-amid og et nitril under fraspaltning af henholdsvis en 30 alkohol eller ammoniak/amin. Reaktionen er generel for de ovennævnte udgangsmaterialer, såvel som for de tau-tomere former, hvori udgangsmaterialerne kan forekomme.The process can be described as the reaction between a 3-aminoacrylic acid ester or a 3-aminoacrylic acid amide and a nitrile under the decomposition of an alcohol or ammonia / amine, respectively. The reaction is general for the above starting materials, as well as for the tauomeric forms in which the starting materials may occur.

Eksempelvis optræder udgangsmaterialerne:For example, the starting materials appear:

DK 160270 BDK 160270 B

33

a. Ethylcyanamid som EtNH-CIN ^==i EtN=C=NHa. Ethyl cyanamide as EtNH-CIN 2 == in EtN = C = NH

b. 3-aminocrotonsyreamid som . h2n nh2 hn nh2 hn nh2b. 3-Aminocrotonic acid amide as. h2n nh2 hn nh2 hn nh2

I I Il I _ i! II I Il I _ i! IN

^0 ' ^0 5 H3c/ ΧΟΗ^ 0 '^ 0 5 H3c / ΧΟΗ

H HH HH HH H

Ligeledes optræder pyrimidinen i forskellige 10 tautomere former: R3 R3 R3Likewise, the pyrimidine appears in various 10 tautomeric forms: R3 R3 R3

2 I 2 I 2 I2 I 2 I 2 I

R ^C^C\/°H R NC^C\C^° R· ^C\*° I I f=* i i *=* i i 15 "ν'" %/ra R1 R1 R1R ^ C ^ C \ / ° H R NC ^ C \ C ^ ° R · ^ C \ * ° I I f = * i i * = * i i 15 "ν '"% / ra R1 R1 R1

Der kan benyttes forskellige hensigtsmæssige 20 udførelsesformer for fremgangsmåden ifølge opfindelsen som angivet i krav 2-10.Various convenient embodiments of the method according to the invention can be used as set forth in claims 2-10.

Reaktionen forløber under tilstedeværelse af base, som kan være et frit alkalimetal eller jordalkali-metal, eller et alkalimetalhydrid, alkalimetalamid, 25 alkalimetalalkoxid, alkalimetalphenolat, alkalimetal-hydroxid, alkalimetalcarbonat eller alkalimetalcarb-oxylat eller en tilsvarende jordalkalimetalforbindelse.The reaction proceeds in the presence of base which may be a free alkali metal or alkaline earth metal, or an alkali metal hydride, alkali metal amide, alkali metal alkoxide, alkali metal phenolate, alkali metal hydroxide, alkali metal carbonate or alkali metal carboxylate or a corresponding alkaline earth metal compound.

Ved reaktionen fremkommer et salt, f.eks. et alkalimetalsalt af pyrimidinen. Den frie pyrimidin kan 30 frigøres herfra ved behandling med en syre såsom en mineralsyre eller en organisk syre.In the reaction, a salt, e.g. an alkali metal salt of the pyrimidine. The free pyrimidine can be released from it by treatment with an acid such as a mineral acid or an organic acid.

Reaktionen forløber under tilstedeværelse af et opløsningsmiddel, som eksempelvis kan være en alkohol, ether, ethylenglycolether, keton eller kulsyreester el-35 ler et alifatisk eller aromatisk carbonhydrid.The reaction proceeds in the presence of a solvent, which may be, for example, an alcohol, ether, ethylene glycol ether, ketone or carbonic acid ester or an aliphatic or aromatic hydrocarbon.

Reaktionen forløber almindeligvis ved en tempe-The reaction usually proceeds at a temp.

DK 160270 BDK 160270 B

4 ratur på mellem 20°C og 180°C, fortrinsvis mellem 80°C og 140°C.In a range of between 20 ° C and 180 ° C, preferably between 80 ° C and 140 ° C.

Der kendes en række fremgangsmåder til fremstilling af industrielt interessante pyrimidiner som be-5 skrevet i det følgende: A. 2-Isopropyl-4-methyl-6-hydroxypyrimidin US patentskrift nr. 4.014.879, US patentskrift 10 nr. 4.496.728 og GB patentskrift nr. 2.083.814 omhandler fremstilling af 2-isopropyl-4-methyl-6-hydroxypyri-midin ud fra isosmørsyrenitril.A number of methods are known for preparing industrially interesting pyrimidines as described below: A. 2-Isopropyl-4-methyl-6-hydroxypyrimidine U.S. Patent No. 4,014,879, U.S. Patent No. 4,496,728, and GB patent 2,083,814 discloses the preparation of 2-isopropyl-4-methyl-6-hydroxypyrimidine from isobutyric acid nitrile.

Isosmøresyrenitril omdannes til isopropylimino-ether ved reaktion med alkohol og tørt hydrogenchlorid.Isobutyric acid nitrile is converted to isopropylimino ether by reaction with alcohol and dry hydrogen chloride.

15 isopropyliminoether omdannes til isopropylamidin ved reaktion med ammoniak. Isopropylamidin reageres med me-thylacetoacetat til 2-isopropyl-4-methyl-6-hydroxypyri-midin.15 isopropylimino ether is converted to isopropylamidine by reaction with ammonia. Isopropylamidine is reacted with methyl acetoacetate to 2-isopropyl-4-methyl-6-hydroxypyrimidine.

I JP patent-abstract nr. 48/39943 beskrives en 20 lignende reaktion ud fra isopropylamidin og diketen, hvorimod der i GB patentskrift nr. 2.027.710 beskrives reaktionen mellem isopropyliminoether og diketen, efterfulgt af reaktion med ammoniak.JP Patent Abstract No. 48/39943 discloses a similar reaction from isopropylamidine and the diket, whereas GB Patent No. 2,027,710 describes the reaction between isopropylimino ether and the diket followed by reaction with ammonia.

US patentskrift nr. 4.052.397, DE offentliggø-25 relsesskrifterne nr. 2.065.698 og nr. 3.344.429 og JP patent-abstracterne nr. 48/26020 og nr. 48/39942 omhandler fremstilling af 2-isopropyl-4-methyl-6-hydroxypyrimidin ved reaktion mellem 3-aminocrotonsyre-amid og isosmørsyresalt, isosmørsyreester eller iso-30 smørsyreanhydrid.U.S. Patent No. 4,052,397, DE Publication No. 2,065,698 and No. 3,344,429 and JP Patent Abstracts No. 48/26020 and No. 48/39942 disclose the preparation of 2-isopropyl-4-methyl -6-hydroxypyrimidine by reaction of 3-aminocrotonic acid amide with isobutyric acid salt, isobutyric acid ester or isobutyric anhydride.

DK 160270 BDK 160270 B

5 B. 2-Dimethylamino-4-methyl-6-hydroxypyrimidin GB patentskrift nr. 1.182.584 omhandler fremstilling af 2-dimethylamino-4-methyl-6-hydroxypyrimi-5 din ud fra dimethylguanidin og ethylacetoacetat.B. 2-Dimethylamino-4-methyl-6-hydroxypyrimidine GB Patent No. 1,182,584 discloses the preparation of 2-dimethylamino-4-methyl-6-hydroxypyrimidine from dimethylguanidine and ethylacetoacetate.

C. 2-Diethylamino-4-methyl-6-hydroxypyrimidin DE offentliggørelsesskrift nr. 2.520.832 omhand-10 ler fremstilling af 2-diethylamino-4-methyl-6-hydroxy-pyrimidin ud fra diethylguanidin og diketen.C. 2-Diethylamino-4-methyl-6-hydroxypyrimidine DE Publication No. 2,520,832 discloses the preparation of 2-diethylamino-4-methyl-6-hydroxy-pyrimidine from diethylguanidine and diketene.

D. 2-Ethylamino-4-methyl-5-butyl-6-hydroxypyrimid in 15 DE offentliggørelsesskrifterne nr. 2.109.880 og nr. 2.308.858 omhandler fremstilling af 2-ethylamino-4-methyl-5-butyl-6-hydroxypyrimidin ud fra ethylguanidin og ethyl-butylacetoacetat.D. 2-Ethylamino-4-methyl-5-butyl-6-hydroxypyrimide in DE Publication No. 2,109,880 and 2,308,858 discloses the preparation of 2-ethylamino-4-methyl-5-butyl-6-hydroxypyrimidine from ethyl guanidine and ethyl butyl acetoacetate.

DE offentliggørelsesskrift nr. 2.008.875 omhand-20 ler fremstilling af 2-methoxy-4-methyl-5-butyl-6-hy-droxypyrimidin ud fra o-methyl-isourinstof og ethyl-butylacetoacetat. Udskiftning af 2-methoxygruppen med en 2-ethylaminogruppe foregår ved reaktion med ethylamin.U.S. Patent No. 2,008,875 discloses the preparation of 2-methoxy-4-methyl-5-butyl-6-hydroxypyrimidine from o-methylisourea and ethyl-butylacetoacetate. The 2-methoxy group is replaced by a 2-ethylamino group by reaction with ethylamine.

25 e. 2-(Di)alkylamino-4-methyl-5-substitueret-6-hydroxy-pyrimidin DE offentliggørelsesskrifterne nr. 2.239.213 og nr. 2.533.710 omhandler fremstilling af 2-{di)alkyl-30 amino-4-methyl-5-substitueret-6-hydroxypyrimidin ud fra nitroguanidin eller thiourinstof og substitueret aceto-acetat. Udskiftning af nitroaminogruppen sker ved reaktion med amin. Udskiftning af mercaptogruppen sker ved methylering og reaktion med amin.25 e. 2- (Di) alkylamino-4-methyl-5-substituted-6-hydroxy-pyrimidine DE Publication No. 2,239,213 and 2,533,710 discloses the preparation of 2- (di) alkyl-30-amino-4 -methyl-5-substituted-6-hydroxypyrimidine from nitroguanidine or thiourea and substituted acetoacetate. The nitroamino group is replaced by reaction with amine. The mercapto group is replaced by methylation and reaction with amine.

DK 160270 BDK 160270 B

66

Fremgangsmåden ifølge opfindelsen adskiller sig fra de således kendte fremgangsmåder til fremstilling af 2,4- eller 2,4,5-substituerede 6-hydroxypyrimidiner ved, at man anvender allerede kendte udgangsmaterialer, 5 men i en ikke tidligere kendt kombination, og det er herved overraskende , at nitriler reagerer med de ifølge opfindelsen anvendte 3- eller 2,3-substituerede 3-aminoacrylsyrederivater med formlen II. Sammenlignet med allerede kendte reaktioner, hvori der anvendes ni-10 triler, er det ved fremgangsmåden ifølge opfindelsen ikke nødvendigt at omdanne nitrilet til den tilsvarende iminoether eller amidin før koblingsreaktionen, og der bliver herved tale om færre reakt ions trin end ved de kendte fremgangsmåder.The process of the invention differs from the methods thus known in the preparation of 2,4- or 2,4,5-substituted 6-hydroxypyrimidines by using already known starting materials, but in a combination not previously known, and surprisingly, nitriles react with the 3- or 2,3-substituted 3-aminoacrylic acid derivatives of formula II used in the invention. Compared to already known reactions employing nitriles, in the process of the invention, it is not necessary to convert the nitrile to the corresponding imino ether or amidine prior to the coupling reaction, and this results in fewer reaction steps than in the known methods.

15 Fremgangsmåden ifølge opfindelsen adskiller sig ligeledes fra de kendte fremgangsmåder ved, at reaktionen er mere generel, og fremgangsmåden ifølge opfindelsen kan derfor anvendes til fremstilling*af en lang række substituerede pyrimidiner, hvis anvendelig-20 hed vil være kendt eller nærliggende for fagmanden.The process of the invention also differs from the known processes in that the reaction is more general and the process of the invention can therefore be used to prepare a wide variety of substituted pyrimidines, the utility of which will be known or obvious to those skilled in the art.

Fremgangsmåden ifølge opfindelsen belyses nærmere gennem de følgende eksempler under henvisning til tegningen, der viser 13C NMR-spektre af de ifølge eksemplerne fremstillede produkter.The method according to the invention is further illustrated by the following examples with reference to the drawing which shows 13C NMR spectra of the products prepared according to the examples.

.250.25

Eksempel 1 I 300 ml isobutanol opløses 23 g natrium under refluks. Når alt natriumet er opløst, køles blandingen 30 lidt og tilsættes 157 g 3-amino-crotonsyre-isobutyl-ester og 69 g isosmørsyrenitril. Herefter opvarmes blandingen til refluks i 3 timer. Reaktionsblandingen oparbejdes som beskrevet under eksempel 7. Den dannede 2-isopropyl-4-methyl-6-hydroxypyrimidin fremkommer som 35 et hvidt til bleggult produkt, der efter tørring har enExample 1 In 300 ml of isobutanol, 23 g of sodium is dissolved under reflux. When all the sodium has dissolved, the mixture is cooled slightly and 157 g of 3-amino-crotonic acid isobutyl ester and 69 g of isobutyric acid nitrile are added. Then the mixture is heated to reflux for 3 hours. The reaction mixture is worked up as described in Example 7. The resulting 2-isopropyl-4-methyl-6-hydroxypyrimidine is obtained as a white to pale yellow product which after drying has a

DK 160270 BDK 160270 B

7 renhed > 95%, bestemt ved HPLC.7 purity> 95% as determined by HPLC.

På tegningen er vist 13C NMR-spektret af produktet i deutereret DMSO [Produkt 1].In the drawing, the 13 C NMR spectrum of the product is shown in deuterated DMSO [Product 1].

5 Eksempel 2Example 2

Til en blanding af 100 g 3-aminocrotonsyreamid opløst i ca. 100 ml flydende ammoniak tilsættes under køling i små portioner 23 g natrium. Når alt natriumet 10 er opløst, opvarmes reaktionsblandingen langsomt under afdestillation af ammoniak. Når temperaturen når 20°C, tilsættes 200 ml toluen, og der opvarmes til refluks.To a mixture of 100 g of 3-aminocrotonic acid amide dissolved in ca. Add 100 ml of liquid ammonia while cooling in small portions 23 g of sodium. When all of the sodium 10 has dissolved, the reaction mixture is heated slowly while distilling off ammonia. When the temperature reaches 20 ° C, 200 ml of toluene is added and heated to reflux.

Ved reflukstemperaturen tildryppes over 1 til 2 timer 69 g isosmørsyrenitril. Efter endt tildrypning holdes 15 temperaturen i yderligere 3 timer ved refluks. Reaktionsblandingen oparbejdes som beskrevet under eksempel 7. Den dannede 2-isopropyl-4-methyl-6-hydroxypyrimidin fremkommer som et hvidt til bleggult produkt, der efter tørring har en renhed > 95%, bestemt ved HPLC.At reflux temperature, 69 g of isobutyric acid nitrile is dropped over 1 to 2 hours. Upon completion of drip, the temperature is kept at reflux for an additional 3 hours. The reaction mixture is worked up as described in Example 7. The resulting 2-isopropyl-4-methyl-6-hydroxypyrimidine is obtained as a white to pale yellow product which, after drying, has a purity> 95% as determined by HPLC.

20 På tegningen er vist ^3C NMR-spektret af produk tet i deutereret DMSO [Produkt 1].20 The drawing shows the 3 C NMR spectrum of the product in deuterated DMSO [Product 1].

Eksempel 3 25 Til en blanding af 143 g 2-methyl-3-amino-cro- tonsyre-ethylester og 70 g dimethylcyanamid og ca. 200 ml tetrahydrofuran, der er opvarmet til refluks, tilsættes i små portioner ialt 23 g natrium. Reaktionsblandingen holdes ved refluks i 3 timer. Reaktionsblan-30 dingen oparbejdes som beskrevet under eksempel 7. Den dannede 2-dimethylamino-4,5-dimethyl-6-hydroxypyrimidin fremkommer som et hvidt til bleggult produkt, der efter tørring har en renhed > 95%, bestemt ved HPLC.Example 3 To a mixture of 143 g of 2-methyl-3-amino-carboxylic acid ethyl ester and 70 g of dimethyl cyanamide and ca. 200 ml of tetrahydrofuran heated to reflux are added in small portions totaling 23 g of sodium. The reaction mixture is kept at reflux for 3 hours. The reaction mixture is worked up as described in Example 7. The resulting 2-dimethylamino-4,5-dimethyl-6-hydroxypyrimidine is obtained as a white to pale yellow product which after drying has a purity> 95% as determined by HPLC.

På tegningen er vist 13C NMR-spektret af pro-35 duktet i deutereret DMSO [Produkt 2].In the drawing, the 13 C NMR spectrum of the product is shown in deuterated DMSO [Product 2].

DK 160270 BDK 160270 B

88

Eksempel 4Example 4

Til en opslæmning af 24 g natriumhydrid i 100 g monoethylenglycoldimethylether, der er opvarmet til re-5 fluks, tildryppes en blanding af 98 g diethylcyanamid og 100 g 3-amino-crotonsyreamid opløst i 100 g monoethylenglycoldimethylether. Reaktionsblandingen holdes ved refluks i 3 timer. Reaktionsblandingen oparbejdes som beskrevet under eksempel 7. Den dannede 2-diethyl-10 amino-4-methyl-6-hydroxypyrimidin fremkommer som et hvidt til bleggult produkt, der efter tørring har en renhed > 95%, bestemt ved HPLC.To a slurry of 24 g of sodium hydride in 100 g of monoethylene glycol dimethyl ether heated to reflux is added dropwise a mixture of 98 g of diethyl cyanamide and 100 g of 3-amino-crotonic acid amide dissolved in 100 g of monoethylene glycol dimethyl ether. The reaction mixture is kept at reflux for 3 hours. The reaction mixture is worked up as described in Example 7. The resulting 2-diethyl-10-amino-4-methyl-6-hydroxypyrimidine is obtained as a white to pale yellow product which, after drying, has a purity> 95% as determined by HPLC.

På tegningen er vist 13C NMR-spektret af produktet i deutereret DMSO [Produkt 3].In the drawing, the 13 C NMR spectrum of the product is shown in deuterated DMSO [Product 3].

1515

Eksempel 5Example 5

En blanding af 157 g 3-amino-crotonsyre-lsobu-tylester og 112 g kalium-tert.-butoxid i ca. 200 ml 20 dioxan opvarmes til refluks og tildryppes over 1-2 timer 98 g diethylcyanamid. Efter endt tildrypning holdes temperaturen yderligere 3 timer ved refluks. Reaktionsblandingen oparbejdes som beskrevet under eksempel 7.A mixture of 157 g of 3-amino-crotonic acid isobutyl ester and 112 g of potassium tert-butoxide in ca. 200 ml of dioxane is heated to reflux and drops 98 g of diethyl cyanamide over 1-2 hours. Upon completion of the drip, the temperature is kept at reflux for an additional 3 hours. The reaction mixture is worked up as described in Example 7.

Den dannede 2-diethylamino-4-methyl-6-hydroxypyrimidin 25 fremkommer som et hvidt til bleggult produkt, der efter tørring har en renhed >95%, bestemt ved HPLC.The resulting 2-diethylamino-4-methyl-6-hydroxypyrimidine 25 appears as a white to pale yellow product which, after drying, has a purity> 95% as determined by HPLC.

På tegningen er vist 13C NMR-spektret af produktet i deutereret DMSO [Produkt 3].In the drawing, the 13 C NMR spectrum of the product is shown in deuterated DMSO [Product 3].

30 Eksempel 6Example 6

En blanding af 100 g 3-amino-crotonsyre-amid, 98 g diethylcyanamid og 56 g kaliumhydroxid i ca. 200 ml tetrahydrofuran opvarmes til refluks i 3 timer. Reak-35 tionsblandingen oparbejdes som beskrevet under eksempelA mixture of 100 g of 3-amino-crotonic acid amide, 98 g of diethyl cyanamide and 56 g of potassium hydroxide in ca. 200 ml of tetrahydrofuran is heated to reflux for 3 hours. The reaction mixture is worked up as described below

DK 160270 BDK 160270 B

9 7. Den dannede 2-diethylamino-4-methyl-6-hydroxypyrimi-din fremkommer som et hvidt til bleggult produkt, der efter tørring har en renhed > 95%, bestemt ved HPLC.9 7. The resulting 2-diethylamino-4-methyl-6-hydroxypyrimidine appears as a white to pale yellow product which, after drying, has a purity> 95% as determined by HPLC.

På tegningen er vist 13C NMR-spektret af pro-5 duktet i deutereret DMSO [Produkt 3].In the drawing, the 13 C NMR spectrum of the product is shown in deuterated DMSO [Product 3].

Eksempel 7Example 7

En blanding af 143 g 2-methyl-3-amino-croton-10 syre-ethylester, 70 g ethylcyanamid og 138 g kalium-carbonat i 300 ml diethylcarbonat opvarmes til refluks i 6 timer. Reaktionsblandingen oparbejdes ved en af følgende metoder: 15 a. Reaktionsblandingen neutraliseres med en mineralsyre (eksempelvis tørt hydrogenchlorid eller kone. svovlsyre) eller en organisk syre (eksempelvis eddikesyre), opvarmes til refluks i Vi time og inddampes på rotationsfordamper til tør-20 hed, hvorpå der tilsættes 200 ml vand.A mixture of 143 g of 2-methyl-3-amino-crotonic acid ethyl ester, 70 g of ethyl cyanamide and 138 g of potassium carbonate in 300 ml of diethyl carbonate is heated to reflux for 6 hours. The reaction mixture is worked up by one of the following methods: 15 a. The reaction mixture is neutralized with a mineral acid (e.g., dry hydrogen chloride or wife. to which 200 ml of water is added.

Produktet udfælder i vandfasen og kan frafil-treres denne.The product precipitates in the aqueous phase and can be filtered off.

b. Reaktionsblandingen inddampes på rotationsfordamper til tørhed, hvorefter der tilsættes 200 25 ml vand. Vandfasen neutraliseres med mineralsy re, hvorved produktet udfældes og kan frafiltre-res denne.b. The reaction mixture is evaporated on a rotary evaporator to dryness and 200 ml of water are added. The aqueous phase is neutralized with mineral acid, whereby the product precipitates and can be filtered off.

Det dannede 2-ethylamino-4,5-dimethyl~6-hydroxy-30 pyrimidin fremkommer som et hvidt til bleggult produkt, der efter tørring har en renhed > 95%, bestemt ved HPLC.The resulting 2-ethylamino-4,5-dimethyl-6-hydroxy-pyrimidine appears as a white to pale yellow product which, after drying, has a purity> 95% as determined by HPLC.

På tegningen er vist 13C NMR-spektret af produktet i deutereret DMSO [Produkt 4].In the drawing, the 13 C NMR spectrum of the product is shown in deuterated DMSO [Product 4].

35 Efter en lignende metode kan 2-ethylamino-4- methyl-5-n-butyl-6-hydroxypyrimidin fremstilles ved an-By a similar method, 2-ethylamino-4-methyl-5-n-butyl-6-hydroxypyrimidine can be prepared by using

DK 160270 BDK 160270 B

10 vendelse af 2-n-butyl-3-amino-crotonsyre-ethylester i stedet for 2-methyl-3-amino-crotonsyre-ethylester.Using 2-n-butyl-3-amino-crotonic acid ethyl ester instead of 2-methyl-3-amino-crotonic acid ethyl ester.

Claims (10)

1. Fremgangsmåde til fremstilling af 2,4- eller 2,4,5-substituerede 6-hydroxypyrimidiner med den almene formel IA process for the preparation of 2,4- or 2,4,5-substituted 6-hydroxypyrimidines of general formula I 2. Fremgangsmåde ifølge krav 1, kende tegnet ved, at den anvendte base er et alkalimetal eller j ordalkalimetal, eller et alkalimetalhydrid, alkalimetalamid eller alkalimetalalkoxid eller en tilsvarende jordalkalimetalforbindelse.Process according to claim 1, characterized in that the base used is an alkali metal or alkaline earth metal, or an alkali metal hydride, alkali metal amide or alkali metal alkoxide or a corresponding alkaline earth metal compound. 2 I R v»® v»°2 I R v »® v» ° 30. I II h2n X DK 160270 B 12 hvori R2 og R3 har de ovennævnte betydninger, og X betegner OR4 eller R5 n/ _ \r6 5 hvori R4 betegner alkyl, aryl eller aralkyl [fortrinsvis CH3, C2H5, n-C3H7, CH(CH3)2, n-C4H9, C(CH3)3, CgHg eller CH2CgHg], og R5 og R6 hver især betegner hydrogen, alkyl eller 10 aralkyl [fortrinsvis H, CH3, C2H5, n-C3H7, CH(CH3)2, n-C4Hg, C(CH3)3, CH2C6H5 eller CH2CH2CgH5], med et nitril med den almene formel III R1-C=N III 15 hvori R1 har den ovennævnte betydning, under tilstedeværelse af en base og et opløsningsmiddel, hvorefter man om ønsket omdanner det dannede salt til den frie pyrimidin med formlen I ved tilsætning af en syre.30. In II h 2n X wherein R 2 and R 3 have the above meanings and X represents OR 4 or R 5 n / R 6 wherein R 4 represents alkyl, aryl or aralkyl [preferably CH 3, C 2 H 5, n-C 3 H 7, CH (CH3) 2, n-C4H9, C (CH3) 3, CgHg or CH2CgHg], and R5 and R6 each represent hydrogen, alkyl or aralkyl [preferably H, CH3, C2H5, n-C3H7, CH (CH3) 2 , n-C4Hg, C (CH3) 3, CH2C6H5 or CH2CH2CgH5], with a nitrile of general formula III R 1 -C = N III 15 wherein R 1 has the above meaning, in the presence of a base and a solvent, desirably, the salt formed converts to the free pyrimidine of formula I by the addition of an acid. 3. Fremgangsmåde ifølge krav 1, kende tegnet ved, at den anvendte base er et alkalime-talphenolat, alkalimetalhydroxid, alkalimetalcarbonat eller alkalimetalcarboxylat eller en tilsvarende jordalkalimetalforbindelse.Process according to claim 1, characterized in that the base used is an alkali metal phenolate, alkali metal hydroxide, alkali metal carbonate or alkali metal carboxylate or a corresponding alkaline earth metal compound. 4. Fremgangsmåde ifølge et vilkårligt af de fo regående krav, kendetegnet ved, at det anvendte opløsningsmiddel er en alkohol, ether, ethylen-glycolether, keton eller kulsyreester eller et alifa-tisk eller aromatisk carbonhydrid.Process according to any one of the preceding claims, characterized in that the solvent used is an alcohol, ether, ethylene-glycol ether, ketone or carbonic acid ester or an aliphatic or aromatic hydrocarbon. 5. Fremgangsmåde ifølge et vilkårligt af de fo regående krav, kendetegnet ved, at reak- DK 160270 B 13 tionstemperaturen er mellem 20°C og 180°C, fortrinsvis mellem 80°C og 140°C.Process according to any of the preceding claims, characterized in that the reaction temperature is between 20 ° C and 180 ° C, preferably between 80 ° C and 140 ° C. 5 R3 *V\/0H 1. ii I N. J ν' io li R1 hvori R1 betegner alkyl [fortrinsvis CH3, C2H5, n-C3H7, CH(CH3)2 eller n-C4H9] eller 15 R7 n/ \r8 R2 betegner alkyl, aryl eller aralkyl [fortrinsvis CH3, C2H5, n-C3H7, CH(CH3)2, n-C4H9, C(CH3)3, CgH5 eller CH2CH2C6H5], ogWherein R 1 represents alkyl [preferably CH 3, C 2 H 5, n-C 3 H 7, CH (CH 3) 2 or n-C 4 H 9] or R 7 n / \ r 8 R 2 represents alkyl, aryl or aralkyl [preferably CH 3, C 2 H 5, n-C 3 H 7, CH (CH 3) 2, n-C 4 H 9, C (CH 3) 3, C 9 H 5 or CH 2 CH 2 C 6 H 5], and 20 R3, R7 og R8 hver især betegner hydrogen, alkyl eller aralkyl [fortrinsvis H, CH3, C2H5, n-C3H7, CH(CH3)2, n-C4H9, C(CH3)3, CH2C6H5 eller CH2CH2C6H5], eller salte heraf med en saltdannende kation, kendetegnet ved, at man omsætter et 3- eller 2,3-subs.titueret 25 3-aminoacrylsyrederivat med den almene formel il R3R3, R7 and R8 each represent hydrogen, alkyl or aralkyl [preferably H, CH3, C2H5, n-C3H7, CH (CH3) 2, n-C4H9, C (CH3) 3, CH2C6H5 or CH2CH2C6H5], or salts thereof with a salt-forming cation, characterized by reacting a 3- or 2,3-substituted 3-aminoacrylic acid derivative of the general formula I R3 6. Fremgangsmåde ifølge et vilkårligt af de foregående krav, kendetegnet ved, at reak- 5 tionsblandingen behandles med en mineralsyre eller en organisk syre.Process according to any one of the preceding claims, characterized in that the reaction mixture is treated with a mineral acid or an organic acid. 7. Fremgangsmåde ifølge et vilkårligt af de foregående krav, kendetegnet ved, at det anvendte nitril med formlen III er isosmørsyrenitril, 10 ethylcyanamid, dimethylcyanamid eller diethylcyanamid.Process according to any one of the preceding claims, characterized in that the nitrile of formula III used is isobutyric acid nitrile, ethyl cyanamide, dimethyl cyanamide or diethyl cyanamide. 8. Fremgangsmåde ifølge et vilkårligt af kravene 1-7, kendetegnet ved, at det anvendte acrylsyrederivat med formlen II er 3-amino-crotonsyre-amid eller en 3-amino-crotonsyreester.Process according to any one of claims 1-7, characterized in that the acrylic acid derivative of formula II used is 3-amino-crotonic acid amide or a 3-amino-crotonic acid ester. 9. Fremgangsmåde ifølge et vilkårligt af kravene 1-7, kendetegnet ved, at det anvendte acrylsyrederivat med formlen II er 2-methyl-3-amino-croton-syreamid eller en 2-methyl-3-amino-crotonsyreester.Process according to any one of claims 1-7, characterized in that the acrylic acid derivative of formula II used is 2-methyl-3-amino-crotonic acid amide or a 2-methyl-3-amino-crotonic acid ester. 10. Fremgangsmåde ifølge et vilkårligt af krave- 20 ne 1-7, kendetegnet ved, at det anvendte acrylsyrederivat med formlen II er 2-n-butyl-3-ami-nocrotonsyreamid eller en 2-n-butyl-3-amino-crotonsyre-ester.Process according to any one of claims 1-7, characterized in that the acrylic acid derivative of formula II used is 2-n-butyl-3-aminocrotonic acid amide or a 2-n-butyl-3-amino-crotonic acid ester.
DK700688A 1988-12-16 1988-12-16 METHOD OF PREPARING 2,4- OR 2,4,5-SUBSTITUTED 6-HYDROXYPYRIMIDINES DK160270C (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
DK700688A DK160270C (en) 1988-12-16 1988-12-16 METHOD OF PREPARING 2,4- OR 2,4,5-SUBSTITUTED 6-HYDROXYPYRIMIDINES
PCT/DK1989/000293 WO1990006918A1 (en) 1988-12-16 1989-12-14 A process for the preparation of 2,4- or 2,4,5-substituted 6-hydroxypyrimidines

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK700688A DK160270C (en) 1988-12-16 1988-12-16 METHOD OF PREPARING 2,4- OR 2,4,5-SUBSTITUTED 6-HYDROXYPYRIMIDINES
DK700688 1988-12-16

Publications (4)

Publication Number Publication Date
DK700688D0 DK700688D0 (en) 1988-12-16
DK700688A DK700688A (en) 1990-06-17
DK160270B true DK160270B (en) 1991-02-18
DK160270C DK160270C (en) 1991-08-05

Family

ID=8149192

Family Applications (1)

Application Number Title Priority Date Filing Date
DK700688A DK160270C (en) 1988-12-16 1988-12-16 METHOD OF PREPARING 2,4- OR 2,4,5-SUBSTITUTED 6-HYDROXYPYRIMIDINES

Country Status (2)

Country Link
DK (1) DK160270C (en)
WO (1) WO1990006918A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2676734B1 (en) * 1991-05-23 1995-05-19 Roussel Uclaf NEW PYRIMIDINE DERIVATIVES, THEIR PREPARATION PROCESS, THE NEW INTERMEDIATES OBTAINED, THEIR APPLICATION AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
AU780907B2 (en) * 1999-04-15 2005-04-21 Basf Aktiengesellschaft Process for the preparation of substituted pyrimidines
US6281358B1 (en) 1999-04-15 2001-08-28 American Cyanamid Company Process for the preparation of substituted pyrimidines
UY35735A (en) 2013-09-16 2015-04-30 Bayer Pharma AG DISTRICTED TRIFLUOROMETILPIRIMIDINONES AND ITS USE
US20180030169A1 (en) * 2016-07-29 2018-02-01 Phillips 66 Company Thermoresponsive polymers

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3642830A1 (en) * 1986-12-16 1988-07-07 Hoechst Ag METHOD FOR PRODUCING PYRIMIDINES

Also Published As

Publication number Publication date
DK160270C (en) 1991-08-05
WO1990006918A1 (en) 1990-06-28
DK700688D0 (en) 1988-12-16
DK700688A (en) 1990-06-17

Similar Documents

Publication Publication Date Title
CA2293011C (en) Process for the preparation of n-(amino-4,6-dihalopyrimidine)formamides
US4891443A (en) N,N'-Dicyanocyclopropanecarbamidines and a process for their preparation
EP0757678B1 (en) Process for the preparation of 4,6-dichloropyrimidine
US5216161A (en) Process for preparing 2,5-diamino-4,6-dichloropyrimidine
DK160270B (en) METHOD OF PREPARING 2,4- OR 2,4,5-SUBSTITUTED 6-HYDROXYPYRIMIDINES
US4650892A (en) Process for the preparation of herbicidal sulfonamides
CA1250574A (en) Process for the preparation of 2-amino-s-triazines
US5717096A (en) Process for the preparation of a 2-alkoxy-6-(trifluoromethyl)pyrimidin-4-ol
US5294710A (en) N-5-protected 2,5-diamino-4,6-dichloropyrimidines and process for their production
CZ22496A3 (en) Process for preparing substituted 4,6-diamino-5-c process for preparing substituted 4,6-diamino-5-cyanpyrimidines and their intermediates yanpyrimidines and their intermediates
EP1927590B1 (en) Method for producing 1-substituted-5-acylimidazole compound
AU622827B2 (en) N,n'-bis-1,3,5-triazin-6-ylpiperazines, and process for their preparation
DK169673B1 (en) Process for the preparation of 4,6-bis (difluoromethoxy) pyrimidines
US5248811A (en) Process for producing sulfoalkyl-substituted hydroxylamines
US5463055A (en) Process for the production of 2-ethoxy-4,6-dihydroxypyrimidine or its alkali salts
DK159681B (en) METHOD FOR PREPARING 2-SUBSTITUTED 5-NITROSO-4,6-DIAMINO-PYRIMIDINES
US2676965A (en) Method of preparing 2-mercapto-4-tertiary aminopyrimidines
CA1221968A (en) Process for the preparation of sulphonyliso(thio)ureas
US5070199A (en) Process for the preparation of 2-amino-4-methyl-6-methoxy-1,3,5-triazine
RU2405775C1 (en) 2-(benzylthio)pyrimidine-4,6-(1h,5h)-dione synthesis method
US10093626B2 (en) Process for preparing piperidine-4-carbothioamide hydrochloride
US4831139A (en) Process for the preparation of 2-substituted 5-nitroso-4,6-diaminopyrimidines
SU1340584A3 (en) Method of producing n-/4-/2-(5-methylpyrazinyl-2-carboxamido)-ethyl/-benzosulfonyl/-n-cyclohexyl-urea
RU1781216C (en) Process for producing monosubstituted 3-pyrimidylthiourreas
Avendano et al. 2, 4, 4‐trisubstituted 5‐amino‐4h‐imidazoles. A new synthetic approach and reactivity

Legal Events

Date Code Title Description
PBP Patent lapsed